ECSP003625A - HYDROXAMIC ACID COMPOUNDS USEFUL AS MATRIX METALOPROTEINASE INHIBITORS - Google Patents
HYDROXAMIC ACID COMPOUNDS USEFUL AS MATRIX METALOPROTEINASE INHIBITORSInfo
- Publication number
- ECSP003625A ECSP003625A ECSP003625A ECSP003625A EC SP003625 A ECSP003625 A EC SP003625A EC SP003625 A ECSP003625 A EC SP003625A EC SP003625 A ECSP003625 A EC SP003625A
- Authority
- EC
- Ecuador
- Prior art keywords
- diseases
- compounds
- methods
- acid compounds
- compounds useful
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Los compuestos de la fórmula (gráfico), son útiles para inhibir las enzimas de metaloproteinasa de matriz en animales, y evita y trata las enfermedades que resultan de la quebradura de tejidos conectivos. Además se decsriben métodos para la preparación de tales compuestos, composiciones farmacéuticas incluyendolos, y métodos de tratamiento de enfermedades en los cuales las metaloproteinasas de matriz son involucradas incluyendo la esclerosis múltiple la ruptura de placa de la arteriosclerosis, la restenosis, la aneurisma aórtica, la cardiopatías, las enfermedades periodontales, úlcera de cérnea, quemaduras, úlceras decubial, úlceras o heridas crónicas, metástasis de cáncer, angiogénesis de tumor, osteoporosis, reuma o osteoartritis enfermedad renal, dilatación ventricular izquierda, u otras enfermedades autoinmune o inflamatorias de la invención de leucocitos en el tejido.The compounds of the formula (graph) are useful for inhibiting matrix metalloproteinase enzymes in animals, and prevents and treats diseases resulting from breakdown of connective tissues. In addition, methods for the preparation of such compounds are described, including pharmaceutical compositions, and methods of treating diseases in which matrix metalloproteinases are involved including multiple sclerosis, rupture of arteriosclerosis plaque, restenosis, aortic aneurysm, heart disease, periodontal diseases, corneal ulcer, burns, decubial ulcers, chronic ulcers or wounds, cancer metastases, tumor angiogenesis, osteoporosis, rheumatism or osteoarthritis kidney disease, left ventricular dilation, or other autoimmune or inflammatory diseases of the invention of leukocytes in the tissue.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP003625 ECSP003625A (en) | 2000-08-17 | 2000-08-17 | HYDROXAMIC ACID COMPOUNDS USEFUL AS MATRIX METALOPROTEINASE INHIBITORS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP003625 ECSP003625A (en) | 2000-08-17 | 2000-08-17 | HYDROXAMIC ACID COMPOUNDS USEFUL AS MATRIX METALOPROTEINASE INHIBITORS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP003625A true ECSP003625A (en) | 2000-11-24 |
Family
ID=42041230
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP003625 ECSP003625A (en) | 2000-08-17 | 2000-08-17 | HYDROXAMIC ACID COMPOUNDS USEFUL AS MATRIX METALOPROTEINASE INHIBITORS |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP003625A (en) |
-
2000
- 2000-08-17 EC ECSP003625 patent/ECSP003625A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY26302A1 (en) | HYDROXAMIC ACID COMPOUNDS USEFUL AS MATRIX METALOPROTEINASE INHIBITORS LAW 17,164 | |
| ECSP044998A (en) | PIRROLO PIRIMIDINAS AS AGENTS FOR THE INHIBITION OF CYSTEINE PROTEASES | |
| HK1051691A1 (en) | Hydroxylstilbenes and stilbene derivatives and analogues of anti-inflammatory and psoriasis treatment and protein kinase inhibition | |
| CY1109333T1 (en) | 3- [4- Heterocyclyl-1,2,3-triazol-1-yl] -N-aryl-benzamide as inhibitors of cytokine production for therapeutic induction | |
| ECSP066383A (en) | DERIVATIVES OF 5-PHENYL-4-METHYL-TIAZOL-2-IL-AMINA AS INHIBITORS OF KINASA ENZYMES PHOSFATIDILINOSITOL 3 (PI3) FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE RESPIRATORY ROUTES | |
| WO2004014844A3 (en) | Aryl and heteroaryl compounds and methods to modulate coagulation | |
| ATE361300T1 (en) | DERIVATIVES OF HETEROARYLNITRIL COMPOUNDS | |
| KR20090040323A (en) | Compositions and methods for the treatment of mucositis | |
| BR9815596A (en) | Compound, pharmaceutical composition, method of treating inflammatory diseases and method of treating condition or disease mediated by mmps and / or tnf and / or agrecanase | |
| WO1997018207A3 (en) | Novel macrocyclic compounds as metalloprotease inhibitors | |
| EA200601212A1 (en) | PHOSPHODESTERASE INHIBITORS, OBTAINING AND THEIR THERAPEUTIC APPLICATION | |
| BR9712794A (en) | Compounds for and a method of inhibiting matrix metalloproteinases | |
| Grzela et al. | The direct inhibition of MMP–2 and MMP–9 by an enzyme alginogel: A possible mechanism of healing support for venous leg ulcers | |
| AP2001002037A0 (en) | Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases. | |
| ATE418965T1 (en) | DRUG TARGETED LOCAL LIPOLYSIS | |
| NO982840L (en) | Aromatic ketoamino acids and their derivatives as inhibitors of matrix metalloproteinases | |
| AR025331A1 (en) | BENCIMIDAZOL DERIVATIVES REPLACED WITH AMINOCARBONYL, PROCEDURES FOR THEIR PREPARATION AND ITS USE AS MEDICATIONS | |
| AR037766A1 (en) | TRIAROMATIC COMPOUNDS ANALOGS OF VITAMIN D, ITS USE, PHARMACEUTICAL AND COSMETIC COMPOSITIONS THAT INCLUDE THEM AND COSMETIC USE OF SUCH COSMETIC COMPOSITIONS | |
| ECSP003625A (en) | HYDROXAMIC ACID COMPOUNDS USEFUL AS MATRIX METALOPROTEINASE INHIBITORS | |
| ATE229514T1 (en) | MACROCYCLIC COMPOUNDS AS METAL PROTEASE INHIBITORS | |
| Enoch et al. | Dystrophic calcification as a cause for non healing leg ulcers | |
| DE50211672D1 (en) | Urokinase INHIBITORS | |
| HUP0301276A2 (en) | Combination therapy for the treatment of estrogen-sensitive disease | |
| AR072120A1 (en) | FENIL-ALQUIL-PIPERAZINAS THAT HAVE TNF MODULATORY ACTIVITY, A COMPOSITE PREPARATION PROCESS, A PHARMACEUTICAL COMPOSITION CONTAINING IT, A COMPOSITE BASED MEDICATION AND THE USE OF THE COMPOUND TO PREPARE A MEDICINAL PRODUCT | |
| Paixão et al. | Pathological findings in a captive senile Western lowland gorilla (Gorilla gorilla gorilla) with chronic renal failure and septic polyarthritis. |